NCT01808976

Brief Summary

Over two million people in the US download health apps onto their smartphones and tablets, with the intent of improving their quality of life. Despite widespread use of these apps, there is relatively little information regarding app user access (do users download health apps and use them more than once), app user engagement (do users follow the app protocols) and app impact on mood, cognition and daily functioning. Our long-term goal is to conduct a future randomized controlled trial investigating access, engagement and impact of two types of mental health apps, apps based on evidence-based therapeutic principles (i.e.: Problem Solving Therapy) and apps based on cognitive neuroscience principles of depression (i.e.: a cognitive training game called Evolution) and compare both to an information only app. Our intent is to conduct this study entirely on mobile devices, in order to investigate access, engagement, and impact in an ecologically valid manner. The purpose of this pilot study is to test the feasibility of conducting our future randomized controlled trial comparing three mobile mental health apps for the management of depressed mood, improvement of cognitive control, and improvement in activities of daily living in people aged 18 and older. Recruitment, consent, randomization, app use and outcome assessment will be conducted entirely on mobile devices. We will recruit 150 people through four different recruitment avenues to determine which avenue results in the most representative sample of our target population (people 18 and older who have symptoms of depression that are interfering with their quality of life). We will also determine the number we need to recruit to have a final sample of 150 people willing to be randomized between the 3 apps and complete an 12-week study of app impact on mood, cognition and function. This pilot will provide information on the completeness of data from a study conducted in this manner, and uncover any other challenges we may face by using mobile devices for data collection, and if we will find differential drop out between app type (e.g.: will more people stop using of the information only app prematurely?). Although we will not have sufficient statistical power to answer questions about comparative effectiveness between the apps, we plan to explore relationships between sample demographics, app use, and improvement in cognitive control on improvements in mood and function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 7, 2013

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 12, 2013

Completed
20 days until next milestone

Study Start

First participant enrolled

April 1, 2013

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
Last Updated

May 4, 2017

Status Verified

May 1, 2017

Enrollment Period

3.8 years

First QC Date

March 7, 2013

Last Update Submit

May 3, 2017

Conditions

Outcome Measures

Primary Outcomes (9)

  • Sheehan Disability Assessment Scale

    Assesses functional impairment in three inter-related domains; work/school, social and family life.

    Up to 3 weeks

  • Patient Global Improvement Scale

    A 7 point scale that requires the clinician to assess how much the patient's illness has improved or worsened relative to a baseline state at the beginning of the intervention.

    Up to 3 weeks

  • Patient Health Questionnaire

    The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment.

    Up to 3 weeks

  • Sheehan Disability Assessment Scale

    Assesses functional impairment in three inter-related domains; work/school, social and family life.

    Week 8

  • Patient Global Improvement Scale

    A 7 point scale that requires the clinician to assess how much the patient's illness has improved or worsened relative to a baseline state at the beginning of the intervention.

    Week 8

  • Patient Health Questionnaire

    The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment.

    Week 8

  • Sheehan Disability Assessment Scale

    Assesses functional impairment in three inter-related domains; work/school, social and family life.

    Week 12

  • Patient Global Improvement Scale

    A 7 point scale that requires the clinician to assess how much the patient's illness has improved or worsened relative to a baseline state at the beginning of the intervention.

    Week 12

  • Patient Health Questionnaire

    The PHQ-9 is the nine item depression scale of the Patient Health Questionnaire. The PHQ-9 is a powerful tool for assisting primary care clinicians in diagnosing depression as well as selecting and monitoring treatment.

    Week 12

Study Arms (3)

Evolution

ACTIVE COMPARATOR

This app is designed to be a cognitive training game that conditions the CCN. This is done by having participants play a multitasking game that targets their perceptual discrimination abilities, selective attention, and visuomotor tracking skills. At the first session, participants will be directed to an initial assessment of each of these cognitive control skills in a single task and dual-task setting (a total of 3 different diagnostics, described below). Each week, this diagnostic phase will reflect the training paradigm they will encounter for that week, as each week the perceptual and tracking challenges will increase.

Behavioral: Evolution

Problem Solving Therapy

EXPERIMENTAL

This app is based on the social problem solving protocol developed by Nezu and D'Zurilla . The app begins with explaining the PST steps. Participants are informed that they can learn each step one session at a time, or they can chose to learn all the steps at once. After each step completed, participants are asked if they want to continue onto the next step or save it for the next session, thus the app tailors itself to the users ability to absorb new information.

Other: Problem Solving Therapy

Basic health push app

ACTIVE COMPARATOR

This app provides daily suggestions for overcoming depressed mood and allows users to track their mood, using the 0-9 scale available for all three apps. In the first app session, participants are given a general education about depression and its known causes and consequences. Participants are told that to overcome mood problems, they must engage in one mood improvement strategy a day and that the app will suggest one to try each day.

Behavioral: Basic health push app

Interventions

this is a mobile app that participants use to solve problems. It will guide participants through a stepwise process for identifying a means for creating action plans.

Problem Solving Therapy
EvolutionBEHAVIORAL

This is a therapeutic video game that targets the cognitive control network, associated with depression. Participants are expected to play the game daily for 20 minutes over 4 weeks.

Evolution

This is an app that send daily tips for improving your mood.

Basic health push app

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • must own smart device (iPhone or ANDROID + iPAD)
  • a total score of 5 or greater on the PHQ-9; OR a score of 2 or greater on at least one of the first two PHQ-9 items AND a score of 2 or greater on the 10th PHQ-9 item
  • English speaking\* (\* as of 12/2016: this arm is closed)
  • Spanish speaking (1st or second language)

You may not qualify if:

  • below 18 years or older
  • does not own a smart device
  • a total score of less than 5 on the PHQ-9
  • less than a score of 2 on the first two PHQ-9 items and less than 2 on the 10th PHQ-9 item

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Web-based; log onto www.brightenstudy.com/spa for details

San Francisco, California, 94110, United States

Location

Related Publications (2)

  • Renn BN, Pratap A, Atkins DC, Mooney SD, Arean PA. Smartphone-Based Passive Assessment of Mobility in Depression: Challenges and Opportunities. Ment Health Phys Act. 2018 Mar;14:136-139. doi: 10.1016/j.mhpa.2018.04.003. Epub 2018 Apr 18.

  • Pratap A, Renn BN, Volponi J, Mooney SD, Gazzaley A, Arean PA, Anguera JA. Using Mobile Apps to Assess and Treat Depression in Hispanic and Latino Populations: Fully Remote Randomized Clinical Trial. J Med Internet Res. 2018 Aug 9;20(8):e10130. doi: 10.2196/10130.

MeSH Terms

Interventions

Biological Evolution

Intervention Hierarchy (Ancestors)

Genetic PhenomenaBiological Phenomena

Study Officials

  • Patricia Arean, Ph.D.

    University of Washington

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 7, 2013

First Posted

March 12, 2013

Study Start

April 1, 2013

Primary Completion

January 1, 2017

Study Completion

February 1, 2017

Last Updated

May 4, 2017

Record last verified: 2017-05

Data Sharing

IPD Sharing
Will share

We plan to release data for sharing once the study is complete.

Locations